Allergan, Inc. (NYSE:AGN)
A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
The Street
Recs
Botox, Juvederm, Restasis, Glaucoma drops, artificial tears...all products to cater to the aging population, which is growing exponentially.
Recs
play on those vain baby boomers, new uses on the horizon...not just the treatment of wrinkles...
Recs
hmm. recommended by some
Recs
Long-term underperform. Poorly managed. Price in the mid-range with P/E a bit on the high side. It may have some room to go up, but long-term won't outperform the S&P500.
Recs
Aging baby boomers need to look good to the grave. AGN is the "Costco" of the cosmetic industry.
Recs
Long term play on vanity, affluence, and longevity of aging baby boomers.
Recs
everybody needs some botox someday
Recs
With leading products for wrinkles, weight loss, and breast augmentation, AGN is well positioned for the long term.
Recs
Products to make people look better? Baby boomers are going to be driving this stock forward in the next few years.
Recs
Vanity Fair
Recs
excellent growth prospects
Recs
they make Botox. Nuff said!
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 53 of 53 : « Previous 1 2 3